Guideline on the clinical use of apheresis procedures for the treatment of patients and collection of cellular therapy products. British Committee for Standards in Haematology

Transfus Med. 2015 Apr;25(2):57-78. doi: 10.1111/tme.12205.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Adult
  • Anemia, Sickle Cell / therapy
  • Autoimmune Diseases / blood
  • Autoimmune Diseases / therapy
  • Blood Component Removal / adverse effects
  • Blood Component Removal / instrumentation
  • Blood Component Removal / methods
  • Blood Component Removal / standards*
  • Blood Donors
  • Child
  • Citrates / adverse effects
  • Fibrinogen / analysis
  • Health Facilities
  • Humans
  • Hyperlipoproteinemia Type II / therapy
  • Leukocyte Reduction Procedures
  • Lipoproteins / blood
  • Lymphoma, T-Cell, Cutaneous / drug therapy
  • Photopheresis / methods
  • Photopheresis / standards
  • Plasma
  • Plasma Exchange / standards
  • Quality Control
  • Syncope, Vasovagal / etiology
  • Thrombotic Microangiopathies / blood
  • Thrombotic Microangiopathies / therapy

Substances

  • Citrates
  • Lipoproteins
  • Fibrinogen